The Midday Tape
Growth is running the table at midday while defensives sit out the rally, and the one stock getting hit hardest, T-Mobile (TMUS), has nothing to do with earnings and everything to do with a satellite.
Growth over defense is the story of the session.
The tape headline out at the open says it plainly: growth sectors are leading Monday trading while defensives trail, and the price action backs it up. The S&P (SPY) is up seven tenths, the Nasdaq-100 (QQQ) is up over a percent, and even small caps (IWM) are participating. Treasuries (TLT) and the dollar (UUP) are barely moved, and oil (USO) is soft, so this looks like a sector-rotation trade into risk rather than a macro repricing. No Fed speak or data surprise is driving the bus, this is a bottom-up, earnings-and-AI-headline tape.
AI capex chatter is doing the heavy lifting under the surface.
Nvidia (NVDA) is up better than 2% after a note framing the stock as now cheaper than the average S&P 500 name even as Wall Street holds record profit estimates. KLA is flagging backlog growth tied directly to AI infrastructure demand, Honeywell is teaming with Nvidia and Dell to chase AI-driven refinery savings, and Nvidia is reportedly expressing interest in a Meta equity offering, another thread tying the chip leader into the broader capex web. Anthropic's IPO filing adds another data point to the AI financing story, with Amazon, Alphabet, Goldman and Morgan Stanley all named as stakeholders in how that plays out. Microsoft (MSFT) is up a percent on a Truist price-target bump to $600, even as the stock separately deals with a Teams outage and a report that it's offering buyouts to roughly 60,000 employees, a headcount story that's being read as cost discipline, not distress.
Single names are moving on their own news.
T-Mobile is the session's biggest casualty, down over 14% on fears that SpaceX could eventually compete directly in wireless, even as Verizon's (VZ) own CEO says that threat is likely years away and a telecom analyst calls the selloff overdone. Intel (INTC) is trading higher after New Street Research upgraded the stock to Buy with a $125 target. Merck (MRK) is the session's odd one out: down over 2% despite two positive Phase 3 readouts, KEYTRUDA hitting its endometrial cancer endpoint and the TroFuse-005 data clearing FDA priority review, plus a Barclays price-target raise to $180. Good data, red stock, a classic sell-the-news. Walmart (WMT) is firmer on the tape, and Accenture (ACN) is lagging, down over 1.5%.
Still ahead this afternoon:
the after-the-bell slate is loaded, Cadence Design Systems, NXP Semiconductors, Nucor, Public Storage, Welltower and Whirlpool all report after the close, giving chipmaking, industrial, REIT and consumer durables reads before tomorrow's open. Watch whether the growth-led rotation holds into those prints or fades on profit-taking.
Bottom line: this is an AI-and-earnings tape, not a macro one, with capex optimism lifting chips and mega-cap tech while a telecom scare and an earnings paradox in pharma remind traders that single-stock risk hasn't gone anywhere.